The Top COVID-19 Vaccine Stocks with Major Catalysts


With COVID-19 cases jumping around the globe, we need a vaccine immediately.

Fortunately, we may be close to one.

Moderna (MRNA) announced its vaccine was found to induce immune responses in every volunteer in a Phase 1 study.

“These early results, published in the New England Journal of Medicine on Tuesday, showed that the vaccine worked to trigger an immune response with mild side effects — fatigue, chills, headache, muscle pain, pain at the injection site — becoming the first US vacc...

Register Now

The Daily Chart Newsletter is available only to members of this site. Register now for FREE. No cost, no obligation, join today.

Already a member? Login below, or click here to register now for free.